← Home / BridgeBio Pharma, Inc. (BBIO)
Stock Analysis

BridgeBio Pharma, Inc. (BBIO)

BBIO
BBIO · Healthcare • Biotechnology
81.50 -1.74%
Track BBIO in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when BBIO price is:
52W Range Position
80%
LOWMIDHIGH
Trend
Constructive
Momentum
Neutral
Updated: 2026-08-23 21:53 UTC
WOI Investment Thesis
Constructive
Current market structure would strengthen above 85.34. Holding above 78.75 preserves the current price structure.
⚖️
✓
Fundamentals
Strong / Negative
✓
Price Structure
Constructive
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
78.75
↗
Break Above
Primary setup confirms above this trigger.
88.12
🎯
Next Objective
No defined objective is currently available for the primary downtrend breakout.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
17
●
Material Agreement
MEDIUM
BBIO material agreement
On August 13, 2026, BridgeBio Pharma, Inc.
8-K Filing • SEC EDGAR
AUG
10
●
Financial Results
HIGH
BBIO reports financial results
On August 10, 2026, BridgeBio Pharma, Inc.
8-K Filing • SEC EDGAR
JUL
2
↗
Equity Offering / Capital Raise
MEDIUM
BBIO equity financing update
(the “Company”) entered into an Investment Agreement (the “Investment Agreement”) with the purchasers identified therein (collectively, the “Purchasers”), including Chinotto Investments, LLC (the “Sixth Street Purchaser”) andHCRx Investments HoldCo, L.P.
8-K Filing • SEC EDGAR
What's Driving BBIO?
▲ Technical confirmation is pending
Momentum is Neutral. Watch Above 88.12 for setup confirmation. Structure risk is Below 78.75.
💼 Business quality remains relevant
Fundamentals remain relevant. Check growth, profitability, cash flow and balance sheet quality.
⚠️ Key risk remains
Below 78.75
Full Analysis Workspace
Technical Signal
Waiting for Confirmation
▲
A technical structure is developing but has not yet reached confirmed active status.
Downtrend Structure
Downtrend line not broken yet · score 0
Trigger
88.12
RSI(14)
50.0
◎
How to read this setup
The nearest decision zone is framed by support around 78.75 and resistance near 85.34. A cleaner push through resistance would improve continuation odds, while a loss of support would weaken the current thesis.
Price Chart
BBIO — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-21
Spec
Speculative premium
Valuation is very demanding relative to current fundamentals; expectations are high.
Market Cap
$16.2B
Company size
EV
$19.1B
Debt-adjusted value
P/S
22.7
Very high
P/B
-6.4
Not meaningful
EV/Sales
26.7
Very high
FCF Yield
-1.98%
Cash return
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Strong
●
Profitability
Negative
≈
Cash Flow
Recovering
⚖
Balance Sheet
Manageable
💵 Revenue
243.68M
↗ Strong
📈 Net Income
-155.89M
↘ Negative
🧮 EPS (Basic)
-0.78
↘ Negative
BridgeBio Pharma, Inc.
Healthcare • Biotechnology
You Might Also Like